Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis

Cai, BS; Dongiovanni, P; Corey, KE; Wang, XB; Shmarakov, IO; Zheng, Z; Kasikara, C; Davra, V; Meroni, M; Chung, RT; Rothlin, CV; Schwabe, RF; Blaner, WS; Birge, RB; Valenti, L; Tabas, I

Cai, BS; Tabas, I (corresponding author), Columbia Univ, Dept Med, Irving Med Ctr, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Pathol, Irving Med Ctr, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Cell Biol & Physiol, Irving Med Ctr, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Cellular Biophys, Irving Med Ctr, New York, NY 10032 USA.

CELL METABOLISM, 2020; 31 (2): 406

Abstract

Nonalcoholic steatohepatitis (NASH) is emerging as a leading cause of chronic liver disease. However, therapeutic options are limited by incomplete un......

Full Text Link